Key facts
- This page summarizes Jonathan M. Adams's Form 4 filing for BIOVIE INC. (BIVI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Feb 2022, 16:24.
Jonathan M. Adams - 02 Feb 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)
- Reporting relationship
- EVP Liver Cirrhosis Programs
- Issuer ticker
- BIVI
- Reported as of
- 02 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2022, 16:24:16 UTC
- Prior SEC filing
- 16 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jonathan Adams
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jonathan M. Adams filed Form 4 for BIOVIE INC. (BIVI) on 16 Feb 2022.
Change
- Previous filing in this sequence was filed on 16 Sep 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIVI
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -2%
- Price
- $0.000000
- Shares after
- 48,630
- Date
- 02 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.